Phio Pharmaceuticals

PHIO59

High Growth

$2.21arrow_drop_up1.34%$0.02

High Growth

Penny Stock

PHIO59

$2.21

arrow_drop_up1.34%$0.02

High Growth

Penny Stock

Performance History

Key Stats
Open	$2.45
Prev. Close	$2.23
EPS	-14.81
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1.90M
PE Ratio	-

	LOW	HIGH
Day Range	2.17	2.48
52 Week Range	2.17	29.07

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-14.81

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Phio Pharmaceuticals (PHIO)

Phio Pharmaceuticals Corp (PHIO) is a biotechnology company that specializes in the development and commercialization of immuno-oncology therapeutics. The company's primary focus is on developing RNA-based therapeutics that target and modulate the immune system to fight cancer. With a strong pipeline of candidates and a unique proprietary platform, Phio Pharmaceuticals Corp is well-positioned to make a significant impact in the rapidly growing field of immuno-oncology.

One of the key factors driving investor interest in Phio Pharmaceuticals Corp is its innovative technology platform. The company's platform allows for the efficient and targeted delivery of RNA-based therapeutics, which have demonstrated significant potential in the treatment of various types of cancer. By harnessing the power of the immune system, Phio Pharmaceuticals Corp's therapeutics have the potential to provide more effective and less toxic treatment options for patients.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Robert J. Bitterman
Headquarters: Marlborough
Employees: 9
Exchange: NASDAQ

Keep an eye on Phio Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Phio Pharmaceuticals's (PHIO) price per share?

The current price per share for Phio Pharmaceuticals (PHIO) is $2.21. The stock has seen a price change of $0.03 recently, indicating a 1.35% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Phio Pharmaceuticals (PHIO)?

For Phio Pharmaceuticals (PHIO), the 52-week high is $29.07, which is 1.22K% from the current price. The 52-week low is $2.17, the current price is 1.61% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Phio Pharmaceuticals (PHIO) a growth stock?

Phio Pharmaceuticals (PHIO) has shown an average price growth of -6.65% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Phio Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Phio Pharmaceuticals (PHIO) stock price performance year to date (YTD)?

As of the latest data, Phio Pharmaceuticals (PHIO) has a year-to-date price change of -68.1%. Over the past month, the stock has experienced a price change of -16.6%. Over the last three months, the change has been -28.71%. Over the past six months, the figure is -68.79%. Looking at a longer horizon, the five-year price change stands at -99.73%.

help

Is Phio Pharmaceuticals (PHIO) a profitable company?

Phio Pharmaceuticals (PHIO) has a net income of -$10.83M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$10.82M. Furthermore, the EBITDA is -$8.57M.

help

What is the market capitalization of Phio Pharmaceuticals (PHIO)?

Phio Pharmaceuticals (PHIO) has a market capitalization of $1.9M. The average daily trading volume is 2.27, indicating the stock's liquidity and investor engagement.